ImmunityBio, Inc.IBRXNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank83
5Y CAGR-12.6%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

5Y CAGR
-12.6%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025668.31%
20242270.58%
2023159.17%
2022-74.30%
202154.38%
20201306.98%
2019-8.51%
20184.44%
20172.27%
2016-81.36%